EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q1 EPS of ($0.56), $0.11 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.39 million versus the consensus estimate of $7.91 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.